Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use of amiloride and multiple sclerosis: registry-based cohort studies.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Receptos to initiate Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
American Society for Cell Biology Annual Meeting
Rituximab and multiple sclerosis.
Opinion: Sex inclusion in basic research drives discovery.
FDA approval announcement for ofatumumab
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.
Gene expression analysis reveals functional pathways of glatiramer acetate activation.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
Biogen Idec submits application to FDA for approval of PLEGRIDY™ (peginterferon beta-1a) in multiple sclerosis
Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.

Pages